why choose us

First received: November 18, 2024

Clinical Trial: NT-101 Topical Ophthalmic Solution in Patients With Wet AMD

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Wet Age Related Macular Degeneration
Wet AMD

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open-Label, Parallel-group, Multicenter Phase 1/2 Study to Evaluate the Safety and Exploratory Efficacy of NT-101 Topical Ophthalmic Solution in Patients With Wet Age-Related Macular Deg

Brief Summary: Phase 1/2 Trial NT-101 Topical Ophthalmic Solution in Patients with Wet Age-Related Macular Degeneration (AMD)

Read more